Joshua Muia on Genetic Alterations Affecting ADAMTS13 Maturation at IPS 2025
Joshua Muia, Associate Investigator at Versiti Blood Research Institute, shared on LinkedIn:
”It was an exciting week presenting work from laboratory at the International Proteolysis Society’s 13th Biannual Meeting in Buzios, Rio de Janeiro, Brazil.”
The International Proteolysis Society’s 13th Biannual Meeting , held in Búzios, Brazil, from October 26–30, 2025, offered an excellent opportunity for scholars and researchers to gather and engage in meaningful discussions on a wide range of topics.
The meeting also served as a valuable platform for networking and building important professional connections within the research community.
At the meeting Joshua Muia presented research from the Versiti Blood Research Institute laboratory on genetic alterations affecting ADAMTS13 maturation.
Stay updated with Hemostasis Today.
-
Apr 2, 2026, 14:39Maria Τektonidou: STAT1 as a Potential Therapeutic Target in Thrombotic Antiphospholipid Syndrome
-
Apr 2, 2026, 14:18Deise Catamo Vaz: WSO Future Stroke Leaders Project Offers A Closing for Large Information Gap in PSCI
-
Apr 2, 2026, 14:18Abdul Mannan: Free Warfarin and Thrombosis Management Tool for Clinicians
-
Apr 2, 2026, 14:06Mike Sharma Named 2026 Hnatyshyn Lecturer for His Profound Impact on Stroke Care – Heart and Stroke
-
Apr 2, 2026, 13:53Ahvie Herskowitz: Therapeutic Plasma Exchange as a Precision Cancer Weapon
-
Apr 2, 2026, 13:51Clare Woodford: New NHS Access to Semaglutide Offers Hope to Prevent Another Stroke or Heart Attack
-
Apr 2, 2026, 13:46Ney Carter Borges: Plaque Erosion Defines a Distinct Mechanistic and Clinical Phenotype in Acute Coronary Syndrome
-
Apr 2, 2026, 13:19John Michael Quinn: Prehospital Whole Blood Remains Critical in Trauma Care
-
Apr 2, 2026, 13:04Dario Bongiovanni: ESC Working Group on Thrombosis Consensus Document Is Now Live